IL-4受体α在骨髓来源成纤维细胞活化及肾纤维化中的关键作用
该研究探讨IL-4受体α(IL-4Rα)在两种实验性肾纤维化模型中骨髓来源成纤维细胞活化中的作用。与野生型小鼠相比,IL-4Rα敲除小鼠肾脏中骨髓来源成纤维细胞和肌成纤维细胞积累减少,α-平滑肌肌动蛋白和细胞外基质蛋白表达受抑,肾纤维化减轻,且STAT6活化被抑制。骨髓嵌合实验及体外实验进一步证实IL-4Rα/STAT6通路介导骨髓单核细胞向成纤维细胞活化,可能成为慢性肾脏病的治疗靶点。
要点
- IL-4Rα缺失减少肾脏骨髓来源成纤维细胞和肌成纤维细胞积聚。
- IL-4Rα敲除抑制STAT6活化并减轻肾纤维化。
- IL-4Rα/STAT6通路或为慢性肾脏病治疗新靶点。
核心结论
- IL-4Rα通过STAT6信号通路促进骨髓来源成纤维细胞活化,导致细胞外基质蛋白产生和肾纤维化发展。
研究设计与样本
- 研究采用两种实验性肾纤维化模型,比较野生型与IL-4Rα敲除小鼠,并进行骨髓嵌合实验和体外细胞实验。
主要发现
- 与野生型小鼠相比,IL-4Rα敲除小鼠肾脏中骨髓来源成纤维细胞和肌成纤维细胞积累更少。
- IL-4Rα缺陷抑制α-平滑肌肌动蛋白和细胞外基质蛋白表达,减轻肾纤维化。
- IL-4Rα缺陷抑制肾脏中STAT6活化。
- 野生型小鼠移植IL-4Rα敲除骨髓细胞后,输尿管梗阻损伤后肾脏髓系成纤维细胞更少且肾纤维化更轻。
- 体外IL-4激活STAT6并刺激小鼠骨髓单核细胞表达α-平滑肌肌动蛋白和纤连蛋白,该效应在IL-4Rα缺失时消失。
临床怎么用
- IL-4Rα/STAT6信号通路可作为慢性肾脏病肾纤维化的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal fibrosis is a common pathway leading to the progression of chronic kidney disease, and bone marrow-derived fibroblasts contribute significantly to the development of renal fibrosis. However, the signaling mechanisms underlying the activation of these fibroblasts are not completely understood. Here, we examined the role of IL-4 receptor α (IL-4Rα) in the activation of myeloid fibroblasts in two experimental models of renal fibrosis. Compared with wild-type mice, IL-4Rα knockout mice accumulated fewer bone marrow-derived fibroblasts and myofibroblasts in their kidneys. IL-4Rα deficiency suppressed the expression of α-smooth muscle actin, extracellular matrix proteins and the development of renal fibrosis. Furthermore, IL-4Rα deficiency inhibited the activation of signal transducer and activator of transcription 6 (STAT6) in the kidney. Moreover, wild-type mice engrafted with bone marrow cells from IL-4Rα knockout mice exhibited fewer myeloid fibroblasts in the kidney and displayed less severe renal fibrosis following ureteral obstructive injury compared with wild-type mice engrafted with wild-type bone marrow cells. In vitro, IL-4 activated STAT6 and stimulated expression of α-smooth muscle actin and fibronectin in mouse bone marrow monocytes. This was abolished in the absence of IL-4Rα. Thus, IL-4Rα plays an important role in bone marrow-derived fibroblast activation, resulting in extracellular matrix protein production and fibrosis development. Hence, the IL-4Rα/STAT6 signaling pathway may serve as a novel therapeutic target for chronic kidney disease.
引用
- Liang H, Zhang Z, Yan J, et al. The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis. Kidney Int. 2017. PMID: 28739140. doi:10.1016/j.kint.2017.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。